FibroBiologics Inc

Research FibroBiologics Inc (FBLG) on Bullrun: market cap USD 4.14M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerFBLG
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 4.14M
• Financial periodFY2025
• Net income-USD 18.65M
• Free cash flow-USD 16.66M

Valuation Snapshot

latest market cap is USD 4.14M.

About FibroBiologics Inc

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis.

Frequently asked questions

What is FibroBiologics Inc's market cap?

FibroBiologics Inc's market capitalization is USD 4.14M.

What does FibroBiologics Inc do?

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases.